Department of Bioengineering and Therapeutic Sciences

School’s PharmD program rises to second place in national rankings

The new ranking comes on the heels of the School's recent update to its PharmD curriculum.

UCSF features expertise in kidney care and work on artificial kidney

A team of kidney experts talk about kidney disease and share their hopes for the future.

UCSF’s first engineering fellowship announces 2020 postdocs

Fernandez Vila, Finbloom, and Martyn selected

Thriving under stress: a QBI seminar with Kathleen Boris-Lawrie

Nuclear proteins activate mTOR-resistant translation of select HIV-1 and host mRNAs

26th Annual Spring Research Seminar

In the annual Spring Research Seminar, current scientific posters created by School of Pharmacy faculty, staff, fellows, residents, and students are presented. During the seminar, the creators of four posters are selected to receive the Gary Rifkind Award, each of which includes a prize of $1,000...

Giacomini honored with Brodie Award in Drug Metabolism and Disposition

Giacomini earned the Brodie Award in Drug Metabolism and Disposition

Sample medications and detailing visits add to costs, Guglielmo argues

Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Modulation of innate immunity by arboviruses; beyond the STING: a QBI seminar with Ana Sesma

The QBI Seminar Series presents Ana Sesma, PhD, professor with tenure in the Department of Microbiology at Icahn School of Medicine at Mount Sinai. She is interested on the modulation of innate immunity by viruses of human health interests, such as dengue, influenza, human immunodeficiency virus...

Pages